Oncology at Boehringer Ingelheim
At Boehringer Ingelheim Oncology, we are genuinely making a difference: For more than 20 years, we are taking cancer on by developing novel therapies with attention to two indication areas: lung cancer and gastrointestinal tumors. Hear Dr. Joerg Barth, Head of the Therapeutic Area Oncology, outline our oncology approach.